| |
 |
Editorial [Hot topic: Novel Approaches to Pharmacogenomic Investigations (Executive Editor: Kelan G. Tantisira)]
|
| |
|
pp.3732-3733 (2) Author: Kelan G. Tantisira
|
| |
|
|
| |
|
Arrhythmia Pharmacogenomics: Methodological Considerations
|
| |
|
pp.3734-3741 (8) Authors: Dan M. Roden, Prince J. Kannankeril, Dawood Darbar
|
| |
|
|
| |
|
Pharmacogenetics of Asthma Therapy
|
| |
|
pp.3742-3753 (12) Authors: Qing Ling Duan, Kelan G. Tantisira
|
| |
|
|
| |
|
Pipeline Pharmacogenetics: A Novel Approach to Integrating Pharmacogenetics into Drug Development
|
| |
|
pp.3754-3763 (10) Authors: P. Anthony Akkari, Thomas W. Swanson, Donna G. Crenshaw, Iris Grossman, Scott Sundseth, Daniel K. Burns, Allen D. Roses
|
| |
|
|
| |
|
Genome-Wide Association Studies of Family Data in Pharmacogenetics: A Case Study
|
| |
|
pp.3764-3772 (9) Authors: Amy Murphy, Jessica Lasky-Su, Kelan G. Tantisira, Augusto A. Litonjua, Christoph Lange, Scott T. Weiss
|
| |
|
|
| |
|
Genetic Mapping of Pharmacogenetic Regulatory Variation
|
| |
|
pp.3773-3781 (9) Author: Benjamin A. Raby
|
| |
|
|
| |
|
Use of Cell Lines in the Investigation of Pharmacogenetic Loci
|
| |
|
pp.3782-3795 (14) Authors: Wei Zhang, M. Eileen Dolan
|
| |
|
|
| |
|
3D-QSAR Studies on a Series of Inhibitors Docked into a New Homology Model of the DNA-PK Receptor
|
| |
|
pp.3796-3825 (30) Authors: Ran Cao, Huahui Zeng, Huabei Zhang
|
| |
|
|
| |
|
Saccharide Modified Pharmaceutical Nanocarriers for Targeted Drug and Gene Delivery
|
| |
|
pp.3826-3836 (11) Authors: Wangyang Yu, Na Zhang, Changjun Li
|
| |
|
|
